Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
06/2001
06/13/2001EP0863132B1 Ketonitrile derivatives and antibacterial agent and drug containing the same
06/13/2001CN1067064C N-(4-fluoro-phenyl)-heteroaryloxyacetamides
06/13/2001CN1067063C Substituted carboxylic acylaniline derivative and plant disease control agent contg. same as active component
06/13/2001CN1067060C Amino acid derivative, process for producing same, agrohorticultural fungicide, and fungicidal method
06/12/2001US6245790 Oxazole compounds useful as PGE2 agonists and antagonists
06/12/2001CA2080917C New pharmacologically active catechol derivatives
06/07/2001WO2001040207A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators
06/07/2001WO2001040201A1 Oxazolidinone derivatives
06/07/2001WO2001039772A1 Pharmaceutical formulations containing zolmitriptan
06/07/2001WO1999063940A3 INHIBITORS OF H+K+-ATPase
06/07/2001DE19958153A1 Oxazolidinon-Derivate Oxazolidinone derivatives
06/07/2001CA2393217A1 Oxazolidinone derivatives
06/07/2001CA2393190A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators
06/06/2001EP1104407A1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors
06/06/2001EP1104300A2 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
06/06/2001CN1298302A Topical administration of oxazolidinones for transdermal delivery
06/06/2001CN1066728C Process for producing epoxide
06/06/2001CN1066723C HIV protease inhibitor intermediate and its producing process
06/05/2001US6242637 Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present
06/05/2001US6242616 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
06/05/2001US6242469 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
06/05/2001US6242448 Trisubstituted-oxazole derivatives as serotonin ligands
05/2001
05/31/2001WO2001038316A2 Sulfonyl oxazole amines and their use as 5-ht6 receptor ligands
05/31/2001WO1999064041A9 Multibinding agents that modulate nmda receptors
05/31/2001DE19956791A1 New 2-heterocyclyl-4-arylsulfonyl-5-amino-oxazole derivatives useful in treatment of central nervous system disorders and as pesticides
05/31/2001CA2389679A1 Novel sulfonyloxazolamines
05/30/2001EP1103552A1 Benzothiepin derivatives, process for the preparation of the same and uses thereof
05/30/2001EP1102757A1 Substituted oxazole and thiazole derivatives as hppar gamma and hppar alpha activators
05/30/2001EP1102756A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
05/30/2001EP1102754A1 Imidazoles and related compounds as alpha-1a agonists
05/30/2001EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors
05/30/2001EP0772708B1 Method of optically brightening polyamides
05/30/2001CN1297355A Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives
05/30/2001CN1066442C Method for manufacture of 4-aryl-2-perfluoroalkyl-3-oxazolin-5-one from arylglycine
05/29/2001US6239153 Insulin sensitivity enhancer with squaline synthesis inhibitor, which shows a potent depressive effect on diabetic hyperglycemia,
05/29/2001US6239152 Oxazolidinone combinatorial libraries, compositions and methods of preparation
05/29/2001US6239138 Vitronectin receptor antagonist
05/29/2001US6239111 Drug for treating brain diseases, enables prevention or treatment of dementia and similar diseases caused by degeneration or sloughing of neurons, an ally sulfide, sulfoxide or sulfone
05/25/2001WO2001036398A1 Benzoxa- and benzthiazoles
05/25/2001WO2001036383A1 Process for the preparation of sulfamides
05/25/2001WO2001036095A1 Polymer-supported lewis acid catalyst
05/25/2001CA2391978A1 Process for the preparation of sulfamides
05/23/2001EP1100802A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF
05/23/2001EP1100801A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein
05/23/2001EP1100789A1 Substituted benzoylcyclohexandiones
05/23/2001EP1100519A1 Multibinding agents that modulate nmda receptors
05/23/2001EP1100495A1 Propenamides as ccr5 modulators
05/23/2001EP1100332A1 Herbicidal phenoxypropionic acid n-alkyl-n-2-fluorophenyl amide compounds
05/23/2001CN1066133C Substituted (hetero) aryl compounds, process for preparation, agents containing them, and their use
05/22/2001US6235912 Sphingosine analogues
05/22/2001US6235901 Can be polymerized and/or copolymerized by catonic polymerization; can be crosslinked and are useful in coatings, inks, overprint varnishes, and surface treatment applications.
05/22/2001US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis
05/22/2001US6235778 Anticoagulants
05/21/2001WO2001032637A1 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
05/21/2001CA2388200A1 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
05/17/2001WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
05/17/2001WO2001034580A1 Heterocycle substituted diphenyl leukotriene antagonists
05/17/2001WO2001034573A1 Compounds
05/17/2001WO2001034561A1 Processes for the preparation of sumatriptan and related compounds
05/17/2001WO2001034200A1 Body weight gain inhibitors
05/17/2001WO2001034135A2 Oncolytic combinations for the treatment of cancer
05/17/2001WO2001005390A3 Method for treating chronic pain using mek inhibitors
05/17/2001CA2391230A1 Heterocycle substituted diphenyl leukotriene antagonists
05/17/2001CA2390932A1 Body weight gain inhibitors
05/17/2001CA2390789A1 Oncolytic combinations for the treatment of cancer
05/17/2001CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
05/17/2001CA2389514A1 Processes for the preparation of sumatriptan and related compounds
05/16/2001EP1099696A2 Preparation of oxazolidine
05/16/2001EP1098897A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
05/16/2001EP0859766B1 Chiral methyl phenyl oxazolidinones
05/16/2001CN1295548A Novel tricyclic compound
05/16/2001CN1295479A Beta 2-adrenergic receptor agonist
05/15/2001US6232330 Therapeutically effective amount of an insulin sensitivity enhancer(pioglitazone,troglitazone and salts) in combination with an aldose reductase inhibitor(tolurestat,epalrestat,imirestat,zenarestat)
05/15/2001US6232057 Achieving enhanced sensitivity and reduced fog using iodide ion releasing compound which can release the iodide ion rapidly.
05/15/2001US6231786 Fluorinated azoles, and their use in liquid-crystalline mixtures
05/15/2001CA2238978C Retroviral protease inhibiting compounds
05/10/2001WO2001032654A2 Novel heterocyclic compounds and their use as medicines
05/10/2001WO2001032636A1 Benzoylcyclohexandione and benzoylpyrazols, method for the production and use thereof as herbicides and plant growth regulators
05/10/2001WO2001032608A1 Process for the preparation of oxyiminoalkanoic acid derivatives
05/10/2001DE19953136A1 Benzoylcyclohexandione und Benzoylpyrazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren Benzoylcyclohexanediones and benzoylpyrazoles, processes for their preparation and their use as herbicides and plant growth regulators
05/10/2001CA2397361A1 Benzoylcyclohexanediones and benzoylpyrazoles, their preparation and their use as herbicides and plant growth regulators
05/10/2001CA2389208A1 Process for the preparation of oxyiminoalkanoic acid derivatives
05/09/2001EP1097925A1 Novel benzoic acid derivatives and processes for the preparation thereof
05/09/2001EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction
05/09/2001EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction
05/09/2001EP1097707A1 Treatment of female sexual dysfunction
05/09/2001EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction
05/09/2001EP1097147A1 Novel angiogenesis inhibitors
05/09/2001EP1096934A1 Oxazolidinones to treat eye infections
05/09/2001EP0813519B1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
05/09/2001CN1294126A Fluoric derivative of N-phenyl-2-oxazolylamine (thiazolylamine) and its preparing process and application
05/09/2001CN1065532C Thiazolidine and oxaxoliding derivatives, their prepn. and their medical use
05/08/2001US6228871 Angiogenesis inhibitors
05/08/2001US6228868 Anticarcinogenic and antitumor agents
05/08/2001CA2324484A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323464A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323191A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323183A1 Compounds for the treatment of female sexual dysfunction
05/03/2001WO2001030770A1 Stereoselective synthesis of oxazoline derivative
05/03/2001WO2001030333A2 Tissue factor antagonists and methods of use thereof